dc.contributorEspinoza Calle, Glenda Iralda
dc.creatorMaldonado Cabrera, Byron René
dc.date.accessioned2023-04-03T14:28:31Z
dc.date.accessioned2023-05-22T16:32:00Z
dc.date.available2023-04-03T14:28:31Z
dc.date.available2023-05-22T16:32:00Z
dc.date.created2023-04-03T14:28:31Z
dc.date.issued2023-04-03
dc.identifierhttp://dspace.ucuenca.edu.ec/handle/123456789/41570
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/6326198
dc.description.abstractLymphomas are a heterogeneous group of lymphoproliferative disorders that are classified according to their histology, of which B-cell lymphomas represent 80% of all lymphomas. Diffuse large B-cell lymphoma (DLCGB) is the most frequent form of lymphoma, representing 30-35% of the total. Several cytotoxic therapies have been developed, which seek a better therapeutic response with the lowest degree of adverse events, the first-line chemotherapy is RCHOP with an adequate response. The factors associated with the response to first-line treatment are stage, age, general condition, LDH levels, tumor burden.
dc.languagespa
dc.publisherUniversidad de Cuenca
dc.relationMEDMI;109
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rightsopenAccess
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional
dc.subjectMedicina
dc.subjectLinfoma
dc.subjectQuimioterapia
dc.subjectCélulas
dc.titlePrevalencia y factores asociados a respuesta completa a la primera línea de quimioterapia en pacientes con diagnóstico de linfoma difuso de células b, en el Instituto del Cáncer Solca Cuenca-Ecuador
dc.typebachelorThesis


Este ítem pertenece a la siguiente institución